Who is at risk? Core mental health symptoms and problematic cannabis use in Germany
Abstract Background and Aims: Cannabis is one of the most used psychoactive substances worldwide. This study presents nationally representative data…
Abstract Background and Aims: Cannabis is one of the most used psychoactive substances worldwide. This study presents nationally representative data…
Abstract Cannabis use disorder (CUD) affects ~22‐million people globally and is characterised by difficulties in cutting down and quitting use,…
Abstract Hintergrund: Bis vor 25 Jahren waren zyklische Brechattacken unter chronischem Cannabiseinfluss nahezu unbekannt. Nach der Legalisierung nichtmedizinischen Cannabis in…
Abstract Background and aims: Opioid maintenance therapy (OMT) is the first-line treatment for opioid use disorder (OUD), reducing opioid use…
Abstract Background: Abrupt cessation of heavy cannabis use can cause a withdrawal syndrome characterised by irritability, anxiety, insomnia, reduced appetite…
Abstract Background: Chronic use of cannabis is associated with an increased risk of psychosocial, mental and physical health impairments. Sociohealth…
Abstract Cannabis is a widely used substance among the youth population, with an estimated 2.8% currently smoking cannabis. Its popularity…
Abstract Introduction and aims: There is increasing interest and evidence for the use of cannabinoid medications in the treatment of…
Abstract We are amidst a global addiction crisis, yet stigmas surrounding addiction counterintuitively prevail. Understanding and appreciating the neurobiology of…
Abstract Despite the significant societal and personal burden of cannabis use, the impact of long‐term use and Cannabis Use Disorder…